5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Clinical trial NCT04689347 · RECRUITING
Trial details
- NCT number
- NCT04689347
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2026-04-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.